Home > Compound List > Compound details
89-77-0 molecular structure
click picture or here to close

(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide

ChemBase ID: 4373
Molecular Formular: C20H25N3O
Molecular Mass: 323.432
Monoisotopic Mass: 323.19976244
SMILES and InChIs

SMILES:
O=C(N(CC)CC)[C@H]1CN([C@H]2C(=C1)c1c3c(C2)c[nH]c3ccc1)C
Canonical SMILES:
CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
InChI:
InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1
InChIKey:
VAYOSLLFUXYJDT-RDTXWAMCSA-N

Cite this record

CBID:4373 http://www.chembase.cn/molecule-4373.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
IUPAC Traditional name
(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
lysergic acid diethylamide
Synonyms
(8β)-9,10-Didehydro-N,N-diethyl-6-methylergoline-8-carboxamide
Lysergic Acid Diethylamide
Lysergide
Lysergic acid diethylamide
LSD-25,
lysergidD

D-lysergic acid diethyl amidD

''N'',''N''- diethyl- D- lysergamide
N,N-Diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide
n,n-diethyl-(+)-lysergamide
Lysergidum [inn-latin]
Lysergide
Diethylamid kyseliny lysergove [czech]
Dextrolysergic acid diethylamide
Delysid
D-lysergic acid n,n-diethylamide
D-lysergic acid diethylamide
D-lysergic acid dethylamide
D-LSD-25
D-LSD
Cupcakes
Cubes
Contact lens
Coffeinum
Clearlight
Chocolate chips
Chief
Cherry top
California sunshine
Brown dots
Blue star
Blue mist
Microdots
Mellow yellow
Mean green
Lysergic acid diethylamide-25
Lysergic acid amide
Lysergaure diethylamid
Lysergamide
Lysergamid
Lucy in the sky with diamonds
Heavenly blue
Greenies
Gelatin chips
Frogs
Flats
Fifty
Ergine
Domes
Lysergic Acid Diethylamide
LSD
LSD-25
(+)-LSD
(+)-lysergic acid diethylamide
9,10-Didehydro-N,N-diethyl-6-methylergoline-8b-carboxamide
Acid
Barrels
Bart simpson
Bartman
Beast
Big f
Blotter acid
Blue acid
Blue cheer
ZEN
Yellows
Window pane
White light
Wedges
Wedding bells
Ubergluben
Trippers
TMA
The hawk
TABS
Sunshine
Sugar lump
Sugar
Strawberry fields
Spoonies
Scapes
Royal blue
Purple microdot
Purple haze
Pearly gates
Paper acid
Owsley
Orange wedges
Orange sunshine
Orange mushroom
N,n-diethyllysergamide
N,n-diethyl-d-lysergamide
acid
CAS Number
89-77-0
50-37-3
EC Number
200-033-2
MDL Number
MFCD00135795
PubChem SID
46506397
24896390
160967805
PubChem CID
5761
CHEBI ID
6605
CHEMBL
263881
Chemspider ID
5558
DrugBank ID
DB04829
IUPHAR ligand ID
17
Unique Ingredient Identifier
8NA5SWF92O
Wikipedia Title
Lysergic_acid_diethylamide

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 17.018362  H Acceptors
H Donor LogD (pH = 5.5) -0.15770875 
LogD (pH = 7.4) 1.6029848  Log P 2.281515 
Molar Refractivity 98.7347 cm3 Polarizability 38.704967 Å3
Polar Surface Area 39.34 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 3.3  LOG S -3.08 
Solubility (Water) 2.70e-01 g/l 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Solubility
Chloroform expand Show data source
Methanol expand Show data source
Pyridine expand Show data source
Apperance
Brown Solid expand Show data source
Melting Point
80-85 °C (176-185°F) expand Show data source
91-93°C expand Show data source
Hydrophobicity(logP)
2.95 [HANSCH,C ET AL. (1995)] expand Show data source
Storage Condition
Controlled Substance, -20°C Freezer expand Show data source
RTECS
KE4100000 expand Show data source
European Hazard Symbols
Highly toxic Highly toxic (T+) expand Show data source
UN Number
2811 expand Show data source
MSDS Link
Download expand Show data source
German water hazard class
3 expand Show data source
Hazard Class
6.1 expand Show data source
Packing Group
2 expand Show data source
Risk Statements
26/27/28-40 expand Show data source
Safety Statements
22-28-36-45 expand Show data source
GHS Pictograms
GHS06 expand Show data source
GHS08 expand Show data source
GHS Signal Word
Danger expand Show data source
GHS Hazard statements
H300-H310-H330-H351 expand Show data source
GHS Precautionary statements
P260-P264-P280-P284-P302 + P350-P310 expand Show data source
Personal Protective Equipment
Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges expand Show data source
RID/ADR
UN 2811 6.1/PG 2 expand Show data source
Drug Control
USDEA Schedule I; Home Office Schedule 1; stupéfiant; kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada expand Show data source
Storage Temperature
-20°C expand Show data source
Admin Routes
Oral, Intravenous, Ocular, Intramuscular expand Show data source
Dependency Liability
Very low expand Show data source
Excretion
Renal expand Show data source
Half Life
3–5 hours expand Show data source
Metabolism
Hepatic expand Show data source
Legal Status
CD (UK) expand Show data source
Schedule 9 (Australia) expand Show data source
Schedule I (US) expand Show data source
Schedule III (Canada) expand Show data source
Pregnancy Category
C (US) expand Show data source
Gene Information
human ... DRD2(1813), HTR1A(3350), HTR2A(3356), HTR2C(3358), HTR6(3362)rat ... Htr1a(24473), Htr2a(29595), Htr2c(25187), Htr7(65032) expand Show data source
Purity
97% expand Show data source
Certificate of Analysis
Download expand Show data source

DETAILS

DETAILS

DrugBank DrugBank Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich TRC TRC
DrugBank - DB04829 external link
Item Information
Drug Groups illicit; withdrawn
Description Debate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence. Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action of LSD on brain chemistry, and varies according to the susceptibility of the individual to the disorder. Many emotionally intense experiences can lead to flashbacks when a person is reminded acutely of the original experience. However, not all published case reports of chronic flashbacks appear to describe an anxious hyper-vigilant state reminiscent of post-traumatic stress disorder.
Toxicity Estimates for the lethal dosage (LD50) of LSD range from 200 μg/kg to more than 1 mg/kg of human body mass, though most sources report that there are no known human cases of such an overdose.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic.
Half Life 3 hours
References
GREINER T, BURCH NR, EDELBERG R: Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum. AMA Arch Neurol Psychiatry. 1958 Feb;79(2):208-10. [Pubmed]
AGHAJANIAN GK, BING OH: PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS. Clin Pharmacol Ther. 1964 Sep-Oct;5:611-4. [Pubmed]
Papac DI, Foltz RL: Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. J Anal Toxicol. 1990 May-Jun;14(3):189-90. [Pubmed]
Nichols DE: Hallucinogens. Pharmacol Ther. 2004 Feb;101(2):131-81. [Pubmed]
Jacobs BL, Heym J, Rasmussen K: Raphe neurons: firing rate correlates with size of drug response. Eur J Pharmacol. 1983 Jun 3;90(2-3):275-8. [Pubmed]
External Links
Wikipedia
Sigma Aldrich - L7007 external link
Biochem/physiol Actions
Potent hallucinogen; non-selective serotonin receptor agonist.
Toronto Research Chemicals - L488010 external link
Potent hallucinogen; non-selective serotonin receptor agonist. Has been used experimentally as adjunct in study and treatment of mental disorders.Controlled substance.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • GREINER T, BURCH NR, EDELBERG R: Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum. AMA Arch Neurol Psychiatry. 1958 Feb;79(2):208-10. Pubmed
  • • AGHAJANIAN GK, BING OH: PERSISTENCE OF LYSERGIC ACID DIETHYLAMIDE IN THE PLASMA OF HUMAN SUBJECTS. Clin Pharmacol Ther. 1964 Sep-Oct;5:611-4. Pubmed
  • • Papac DI, Foltz RL: Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. J Anal Toxicol. 1990 May-Jun;14(3):189-90. Pubmed
  • • Jacobs BL, Heym J, Rasmussen K: Raphe neurons: firing rate correlates with size of drug response. Eur J Pharmacol. 1983 Jun 3;90(2-3):275-8. Pubmed
  • • Nichols DE: Hallucinogens. Pharmacol Ther. 2004 Feb;101(2):131-81. Pubmed
  • • Hoffer, et al.: Clin. Pharmacol. Ther., 6, 183 (1965)
  • • Keller, U., et al.: Biochemistry, 27, 6164 (1965)
  • • Mey, G., et al.: Mol. Microbiol., 46, 305 (1965)
  • • Steiner, U., et al.: Planta, 224, 533 (1965)
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle